Page last updated: 2024-10-18

glycine and Refractory Depression

glycine has been researched along with Refractory Depression in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Park, LT1
Kadriu, B1
Gould, TD1
Zanos, P1
Greenstein, D1
Evans, JW1
Yuan, P1
Farmer, CA1
Oppenheimer, M1
George, JM1
Adeojo, LW1
Snodgrass, HR1
Smith, MA1
Henter, ID1
Machado-Vieira, R1
Mannes, AJ1
Zarate, CA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
An Investigation of the Antidepressant Effects of the Glycine Receptor Antagonist AV 101 (4-chlorokynurenine) in Major Depressive Disorder[NCT02484456]Phase 222 participants (Actual)Interventional2015-10-14Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Model Adjusted Means for Beck Depression Score

The Beck Depression Inventory (BDI) is a 21-item measure of depression with each question on a 4-point scale ranging from 0=minimal to 3 = more severe (full list score values = 0,1,2,3). Total scores are a sum of individual items. The minimal depression = 0-13, mild depression = 14-19, moderate depression = 20-28, and severe depression = 29-63. The maximum score being 63 and the minimum possible score = 0. (NCT02484456)
Timeframe: Post Dose Day 0

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)25.35
Placebo25.79

Model Adjusted Means for Beck Depression Score

The Beck Depression Inventory (BDI) is a 21-item measure of depression with each question on a 4-point scale ranging from 0=minimal to 3 = more severe (full list score values = 0,1,2,3). Total scores are a sum of individual items. The minimal depression = 0-13, mild depression = 14-19, moderate depression = 20-28, and severe depression = 29-63. The maximum score being 63 and the minimum possible score = 0. (NCT02484456)
Timeframe: Post Dose Day 1

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)24.76
Placebo24.75

Model Adjusted Means for Beck Depression Score

The Beck Depression Inventory (BDI) is a 21-item measure of depression with each question on a 4-point scale ranging from 0=minimal to 3 = more severe (full list score values = 0,1,2,3). Total scores are a sum of individual items. The minimal depression = 0-13, mild depression = 14-19, moderate depression = 20-28, and severe depression = 29-63. The maximum score being 63 and the minimum possible score = 0. (NCT02484456)
Timeframe: Post Dose Day 13

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)25.86
Placebo23.84

Model Adjusted Means for Beck Depression Score

The Beck Depression Inventory (BDI) is a 21-item measure of depression with each question on a 4-point scale ranging from 0=minimal to 3 = more severe (full list score values = 0,1,2,3). Total scores are a sum of individual items. The minimal depression = 0-13, mild depression = 14-19, moderate depression = 20-28, and severe depression = 29-63. The maximum score being 63 and the minimum possible score = 0. (NCT02484456)
Timeframe: Post Dose Day 2

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)25.88
Placebo26.14

Model Adjusted Means for Beck Depression Score

The Beck Depression Inventory (BDI) is a 21-item measure of depression with each question on a 4-point scale ranging from 0=minimal to 3 = more severe (full list score values = 0,1,2,3). Total scores are a sum of individual items. The minimal depression = 0-13, mild depression = 14-19, moderate depression = 20-28, and severe depression = 29-63. The maximum score being 63 and the minimum possible score = 0. (NCT02484456)
Timeframe: Post Dose Day 3

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)25.64
Placebo24.64

Model Adjusted Means for Beck Depression Score

The Beck Depression Inventory (BDI) is a 21-item measure of depression with each question on a 4-point scale ranging from 0=minimal to 3 = more severe (full list score values = 0,1,2,3). Total scores are a sum of individual items. The minimal depression = 0-13, mild depression = 14-19, moderate depression = 20-28, and severe depression = 29-63. The maximum score being 63 and the minimum possible score = 0. (NCT02484456)
Timeframe: Post Dose Day 7

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)25.82
Placebo24.22

Model Adjusted Means for Hamilton Anxiety Rating Score

The Hamilton Anxiety Rating Scale (HAM-A) is a 14-item global measure of anxiety symptoms. Each item is scored on a scale of 0 (not present) to 4 (severe) (full score list = 0,1,2,3,4), with a total score range of 0-56 (0 = minimum score and 56 = maximum), where <17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe. Total scores are a sum of individual items. (NCT02484456)
Timeframe: Post Dose Day 0

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)15.71
Placebo16.20

Model Adjusted Means for Hamilton Anxiety Rating Score

The Hamilton Anxiety Rating Scale (HAM-A) is a 14-item global measure of anxiety symptoms. Each item is scored on a scale of 0 (not present) to 4 (severe) (full score list = 0,1,2,3,4), with a total score range of 0-56 (0 = minimum score and 56 = maximum), where <17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe. Total scores are a sum of individual items. (NCT02484456)
Timeframe: Post Dose Day 1

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)17.30
Placebo16.67

Model Adjusted Means for Hamilton Anxiety Rating Score

The Hamilton Anxiety Rating Scale (HAM-A) is a 14-item global measure of anxiety symptoms. Each item is scored on a scale of 0 (not present) to 4 (severe) (full score list = 0,1,2,3,4), with a total score range of 0-56 (0 = minimum score and 56 = maximum), where <17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe. Total scores are a sum of individual items. (NCT02484456)
Timeframe: Post Dose Day 13

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)18.33
Placebo16.28

Model Adjusted Means for Hamilton Anxiety Rating Score

The Hamilton Anxiety Rating Scale (HAM-A) is a 14-item global measure of anxiety symptoms. Each item is scored on a scale of 0 (not present) to 4 (severe) (full score list = 0,1,2,3,4), with a total score range of 0-56 (0 = minimum score and 56 = maximum), where <17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe. Total scores are a sum of individual items. (NCT02484456)
Timeframe: Post Dose Day 2

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)17.83
Placebo17.66

Model Adjusted Means for Hamilton Anxiety Rating Score

The Hamilton Anxiety Rating Scale (HAM-A) is a 14-item global measure of anxiety symptoms. Each item is scored on a scale of 0 (not present) to 4 (severe) (full score list = 0,1,2,3,4), with a total score range of 0-56 (0 = minimum score and 56 = maximum), where <17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe. Total scores are a sum of individual items. (NCT02484456)
Timeframe: Post Dose Day 3

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)16.48
Placebo17.87

Model Adjusted Means for Hamilton Anxiety Rating Score

The Hamilton Anxiety Rating Scale (HAM-A) is a 14-item global measure of anxiety symptoms. Each item is scored on a scale of 0 (not present) to 4 (severe) (full score list = 0,1,2,3,4), with a total score range of 0-56 (0 = minimum score and 56 = maximum), where <17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe. Total scores are a sum of individual items. (NCT02484456)
Timeframe: Post Dose Day 7

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)18.42
Placebo17.25

Model Adjusted Means for Hamilton Depression Rating Score

The Hamilton Depression Rating scale is a 17-item global measure of depressive symptoms on a 5-point scale ranging from 0 = not present to 4 = severe (full score values = 0,1,2,3,4). Some items rated on a scale of 0-2 (0, 1, 2) with 0 = not present to 2 = more severe. Total scores are a sum of the individual items. The maximum total score being 52 on the 17-point scale, and the minimum score being 0.Total scores of 0-7 are considered as being normal, 8-16 suggest mild depression, 17-23 moderate depression and scores over 24 are indicative of severe depression. (NCT02484456)
Timeframe: Post Dose Day 0

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)20.22
Placebo20.56

Model Adjusted Means for Hamilton Depression Rating Score

The Hamilton Depression Rating scale is a 17-item global measure of depressive symptoms on a 5-point scale ranging from 0 = not present to 4 = severe (full score values = 0,1,2,3,4). Some items rated on a scale of 0-2 (0, 1, 2) with 0 = not present to 2 = more severe. Total scores are a sum of the individual items. The maximum total score being 52 on the 17-point scale, and the minimum score being 0.Total scores of 0-7 are considered as being normal, 8-16 suggest mild depression, 17-23 moderate depression and scores over 24 are indicative of severe depression. (NCT02484456)
Timeframe: Post Dose Day 1

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)20.22
Placebo20.06

Model Adjusted Means for Hamilton Depression Rating Score

The Hamilton Depression Rating scale is a 17-item global measure of depressive symptoms on a 5-point scale ranging from 0 = not present to 4 = severe (full score values = 0,1,2,3,4). Some items rated on a scale of 0-2 (0, 1, 2) with 0 = not present to 2 = more severe. Total scores are a sum of the individual items. The maximum total score being 52 on the 17-point scale, and the minimum score being 0.Total scores of 0-7 are considered as being normal, 8-16 suggest mild depression, 17-23 moderate depression and scores over 24 are indicative of severe depression. (NCT02484456)
Timeframe: Post Dose Day 13

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)21.52
Placebo19.69

Model Adjusted Means for Hamilton Depression Rating Score

The Hamilton Depression Rating scale is a 17-item global measure of depressive symptoms on a 5-point scale ranging from 0 = not present to 4 = severe (full score values = 0,1,2,3,4). Some items rated on a scale of 0-2 (0, 1, 2) with 0 = not present to 2 = more severe. Total scores are a sum of the individual items. The maximum total score being 52 on the 17-point scale, and the minimum score being 0.Total scores of 0-7 are considered as being normal, 8-16 suggest mild depression, 17-23 moderate depression and scores over 24 are indicative of severe depression. (NCT02484456)
Timeframe: Post Dose Day 2

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)20.75
Placebo20.41

Model Adjusted Means for Hamilton Depression Rating Score

The Hamilton Depression Rating scale is a 17-item global measure of depressive symptoms on a 5-point scale ranging from 0 = not present to 4 = severe (full score values = 0,1,2,3,4). Some items rated on a scale of 0-2 (0, 1, 2) with 0 = not present to 2 = more severe. Total scores are a sum of the individual items. The maximum total score being 52 on the 17-point scale, and the minimum score being 0.Total scores of 0-7 are considered as being normal, 8-16 suggest mild depression, 17-23 moderate depression and scores over 24 are indicative of severe depression. (NCT02484456)
Timeframe: Post Dose Day 3

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)19.51
Placebo20.74

Model Adjusted Means for Hamilton Depression Rating Score

The Hamilton Depression Rating scale is a 17-item global measure of depressive symptoms on a 5-point scale ranging from 0 = not present to 4 = severe (full score values = 0,1,2,3,4). Some items rated on a scale of 0-2 (0, 1, 2) with 0 = not present to 2 = more severe. Total scores are a sum of the individual items. The maximum total score being 52 on the 17-point scale, and the minimum score being 0.Total scores of 0-7 are considered as being normal, 8-16 suggest mild depression, 17-23 moderate depression and scores over 24 are indicative of severe depression. (NCT02484456)
Timeframe: Post Dose Day 7

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)21.28
Placebo20.43

Model Adjusted Means for Montgomery-Asberg Depression Rating Score

"The Montgomery-Asberg Depression Rating Scale (MADRS) is a 10-item global measure evaluating core symptoms of depression. Questions concern how the patient has felt over the past week. Each item is rated on a scale from 0 to 6, with 0 being normal/not present and 6 being extreme (full score list = 0,1,2,3,4,5,6). Maximum score = 60, minimum score = 0. Total scores are a sum of the individual items." (NCT02484456)
Timeframe: Post Dose Day 0

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)29.28
Placebo29.48

Model Adjusted Means for Montgomery-Asberg Depression Rating Score

"The Montgomery-Asberg Depression Rating Scale (MADRS) is a 10-item global measure evaluating core symptoms of depression. Questions concern how the patient has felt over the past week. Each item is rated on a scale from 0 to 6, with 0 being normal/not present and 6 being extreme (full score list = 0,1,2,3,4,5,6). Maximum score = 60, minimum score = 0. Total scores are a sum of the individual items." (NCT02484456)
Timeframe: Post Dose Day 1

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)28.75
Placebo28.79

Model Adjusted Means for Montgomery-Asberg Depression Rating Score

"The Montgomery-Asberg Depression Rating Scale (MADRS) is a 10-item global measure evaluating core symptoms of depression. Questions concern how the patient has felt over the past week. Each item is rated on a scale from 0 to 6, with 0 being normal/not present and 6 being extreme (full score list = 0,1,2,3,4,5,6). Maximum score = 60, minimum score = 0. Total scores are a sum of the individual items." (NCT02484456)
Timeframe: Post Dose Day 13

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)29.70
Placebo27.06

Model Adjusted Means for Montgomery-Asberg Depression Rating Score

"The Montgomery-Asberg Depression Rating Scale (MADRS) is a 10-item global measure evaluating core symptoms of depression. Questions concern how the patient has felt over the past week. Each item is rated on a scale from 0 to 6, with 0 being normal/not present and 6 being extreme (full score list = 0,1,2,3,4,5,6). Maximum score = 60, minimum score = 0. Total scores are a sum of the individual items." (NCT02484456)
Timeframe: Post Dose Day 2

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)29.51
Placebo29.84

Model Adjusted Means for Montgomery-Asberg Depression Rating Score

"The Montgomery-Asberg Depression Rating Scale (MADRS) is a 10-item global measure evaluating core symptoms of depression. Questions concern how the patient has felt over the past week. Each item is rated on a scale from 0 to 6, with 0 being normal/not present and 6 being extreme (full score list = 0,1,2,3,4,5,6). Maximum score = 60, minimum score = 0. Total scores are a sum of the individual items." (NCT02484456)
Timeframe: Post Dose Day 3

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)29.85
Placebo30.81

Model Adjusted Means for Montgomery-Asberg Depression Rating Score

"The Montgomery-Asberg Depression Rating Scale (MADRS) is a 10-item global measure evaluating core symptoms of depression. Questions concern how the patient has felt over the past week. Each item is rated on a scale from 0 to 6, with 0 being normal/not present and 6 being extreme (full score list = 0,1,2,3,4,5,6). Maximum score = 60, minimum score = 0. Total scores are a sum of the individual items." (NCT02484456)
Timeframe: Post Dose Day 7

Interventionscore on a scale (Mean)
AV 101 (4-chlorokynurenine)30.45
Placebo28.64

Trials

1 trial available for glycine and Refractory Depression

ArticleYear
A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression.
    The international journal of neuropsychopharmacology, 2020, 07-29, Volume: 23, Issue:7

    Topics: Adolescent; Adult; Aged; Animals; Antidepressive Agents; Brain; Brain Chemistry; Cross-Over Studies;

2020